Project Green MDI

Project Green MDI: Next Generation Metered Dose Inhalers:
Promise for our Patients and the Planet

including Explore With Experts Panel Discussion
Tuesday • May 3, 2022 • 8:30–12:00 Noon EDT • National Ballroom
Moderators: Stephen Stein, Kindeva Drug Delivery & David Lewis, Oz-UK Limited
Evolving Legislation Associated with Fluorinated Hydrocarbon Propellants used in Metered Dose Inhalers
Maureen Hardwick
International Pharmaceutical Aerosol Consortium
The Formulator's Guide to Transitioning to Low Global Warming Potential pMDIs
Jag Shur
Nanopharm, an Aptar Pharma Company
Considerations for Robust Clinical and Commercial Manufacturing of Next Generation Sustainable Metered Dose Inhalers
Nick Atkinson
Recipharm
Safety, Tolerance and Pharmacokinetics of HFA-152a in Healthy Volunteers
Philip Kuehl
Lovelace Biomedical
A Journey to Net Zero Using Solstice Air
Ryan Hulse
Honeywell
EXPLORE WITH EXPERTS
Next Generation Metered Dose Inhalers:
Promise for our Patients and the Planet
Moderators: Stephen Stein, Kindeva Drug Delivery and David Lewis, Oz-UK Limited

Discover More

Sustainable pMDI Filling And Flammable Propellant Handling
Paul Sullivan
DH Industries
JG
Future Challenges Facing Metered-dose Inhalers: Sustainability And Effective Delivery Of Complex Molecules
Richard Turner and Jacqueline Green
H&T Presspart
Sustainable pMDIs – Is Nirvana Within Reach?
Stephen Stein, Neha Patel and Annette Purrington
Kindeva Drug Delivery
HFA-152a Roadmap to Commercialization
Stuart Corr
Koura
LGBL
Investigation of Leachables from pMDIs Containing Propellants HFA 134a, HFA 152a and HFO 1234ze
Laura Gillard and Bruno Lecorre
Aptar Pharma
ASAS
Investigating the Impact of Electrostatics on Delivered Dose Uniformity for pMDIs
Anna Sipitanou and Adam Smith
Copley Scientific
JG
Plasma Technology: An Innovative and Sustainable pMDI Surface Treatment
Jacqueline Green
H&T Presspart
AS
The Use of Accelerated Stability Storage to Fast-Track the Development of a New Metered Dose Inhaler Incorporating the Greener Propellant HFA-152a
Alex Slowey and Benjamin Myatt
Kindeva Drug Delivery
The Combined Effect of Valve and Spray Orifice Diameters on pMDI Plume Force
Benjamin Myatt
Kindeva Drug Delivery
Paving the Way to pMDI Propellant Transition - A Laboratory Assessment of P152a-Based Formulation Performance used with a Commonly Referenced Spacer
Jason Suggett
Trudell Medical International
What Part does the Tongue Play in the Transport of Inhaled Medications? An Experimental Study Using Adult Oropharyngeal Models
Jolyon Mitchell and Mark Nagel
Trudell Medical International
Effects of Formulation and Actuator Design on Spray Velocity of Mometasone Furoate Metered Dose Inhalers
Sneha Dhapare
U.S. Food & Drug Administration
The Effects of Inhalation Flow Rate on Aerodynamic Particle Size Distribution of Commercial Solution and Suspension Metered Dose Inhalers
Abhinav Mohan
U.S. Food & Drug Administration
Predicting Aerosol Performance of pMDIs Containing Low-GWP Propellants using a One-Dimensional Thermofluid-Mechanic Model
Benjamin Thorne
University of Hertfordshire
CONFERENCE SUPPORTERS
WORKSHOP PRESENTERS
EXHIBITORS

Exhibitors

↑ Back to Top